Insider Look at Rabacfosadine (Tanovea) from Shelved Human Drug to Dog Lymphoma Treatment | Dr. Doug Thamm #284
How was Tanovea developed from a shelved human drug, and what are its uses and benefits in treating canine lymphoma?
Dr. Doug Thamm discusses the development and use of Tanovea, a drug for treating lymphoma in dogs. He explains the drug's origins, initially researched as a human cancer therapeutic in collaboration with Gilead Sciences, and its transition to veterinary use.
Dr. Thamm provides insights into Tanovea’s application, dosage, and effectiveness compared to the CHOP protocol, as well as its potential side effects and other possible uses in different cancer types like multiple myeloma. The episode also delves into related immunotherapy research and personal reflections from Dr. Thamm, a double cancer survivor, on his career choice in veterinary oncology.
Your Voice Matters!
If you have a question for our team, or if you want to share your own hopeful dog cancer story, we want to hear from you! Go to https://www.dogcancer.com/ask to submit your question or story, or call our Listener Line at +1 808-868-3200 to leave a question.
Related Videos:
https://www.youtube.com/watch?v=G0iRyKshzq8
Related Links:
Our article on lymphoma: https://www.dogcancer.com/articles/types-of-dog-cancer/lymphoma-in-dogs/
Our article on Tanovea: https://www.dogcancer.com/articles/drugs/tanovea-rabacfosadine-chemotherapy/
Get the facts on dog cancer remission: https://www.dogcancer.com/articles/stats-and-facts/dog-cancer-remission/
Chapters:
00:00 Introduction
00:13 Interview with Dr. Doug Thamm
00:26 The Early Involvement with Tanovea
00:41 Challenges and Discoveries in Drug Development
02:16 Transition from Human to Veterinary Use
02:48 Clinical Trials and Dosage Experiments
06:45 FDA Approval and Practical Use
08:05 Comparing Tanovea and CHOP Protocol
15:23 Exploring Alternative Treatments: Laverdia
18:43 Off-Label Uses and Future Research
23:46 Exploring Tanovea's Effectiveness in Blood Cancers
25:14 Cost Comparison: Tanovea vs. CHOP
26:15 Side Effects of Tanovea
28:47 Pulmonary Fibrosis and Breed-Specific Risks
32:52 Personal Cancer Journeys: Dr. Doug and His Wife
38:23 Debunking Myths About Dog Cancer Treatment
42:24 The Future of Cancer Treatment: Immunotherapy
45:23 Conclusion and Resources
Get to know Dr. Doug Thamm:
https://www.dogcancer.com/people/doug-Thammm-v-m-d-diplomate-acvim-oncology/
For more details, articles, podcast episodes, and quality education, go to the episode page: https://www.dogcancer.com/podcast/
Learn more about your ad choices. Visit megaphone.fm/adchoices